학술논문
갑상선암의 외과적 치료
이용수 0
- 영문명
- Surgical Treatment of Thyroid Carcinoma -A Relation between Prognostic Factors and Survival Rate-
- 발행기관
- 대한두경부종양학회
- 저자명
- 김재홍(Jae Hong Kim) 오상훈(Sang Hoon Oh) 김상효(Sang Hyo Kim) 백낙환(Nak Whan Paik)
- 간행물 정보
- 『대한두경부종양학회지』제13권 제2호, 187~199쪽, 전체 13쪽
- 주제분류
- 의약학 > 종양학
- 파일형태
- 발행일자
- 1997.11.30
4,360원
구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

국문 초록
영문 초록
Thyroid carcinoma ranks low in incidence and as a cause of death when compared to carcinomas arising in the other site. With adequate surgical treatment, the prognosis of operable thyroid carcinoma is good. However, the extent of surgical resection in treatment of thyroid cancer remains still controversy. The aim of this study was to assess the results of thyroid cancer patients treated surgically and to analyze the prognostic factors affecting survival and to improve the survival rate. We retrospectively analyzed the outcome of a total of 278 thyroid cancer patients treated surgically at Inje University Paik Hospital from 1980 to 1995 and followed for 1 to 16 years.
There were man in 47 and woman in 231 patients with age range of 14 to 79 years(mean 42 years). Histopathologic findings were papillary carcinoma in 233, follicular carcinoma in 33, mixed carcinoma in 7, medullary carcinoma in 2, and undifferentiated carcinoma in 3 patients, respectively. Operative procedures were unilateral lobectomy in 111, subtotal thyroidectomy in 100, and total thyroidectomy in 67 patients. Central node dissection was performed in 92, modified neck disseciton in 62, radical neck dissection in 28, and no node dissection in 96 patients. Thyroid hormone was administered for the period of 3 to 5 years to suppress endogenous TSH production. Overall 5-year survival rate according to Kaplan-Meier method was 91.1%. Independently, significant factors affecting the prognosis were age at diagnosis, tumor size, pathologic type, tumor stage, lymph node metastasis, angioinvasion, extrathyroidal extension, and 'risk' group category. but, the prognosis were not influenced by sex and capsular invasion.
Patients at low risk or with small size carcinomas had long survival over 5 years with only lobectomy. Lymph node dissection was carried out with a limited type in no jugular metastasis, radical neck dissection was performed only therapeutically in proved jugular node metastasis.
Fifteen patients were dead of tumor recurrence after surviving for three months to two and half years, and the cause of death was local recurrence in nine, bone metastasis in four and lung metastasis in two patients.
In conclusion, more extensive surgery including total thyroidecotmy and systematic compartment-oriented dissection of the lymph node metastases in patient at high-risk group will results in better survival and lower recurrence rate.
목차
Abstract
서론
대상 및 방법
관찰성적
고찰
겨론
References
해당간행물 수록 논문
- 갑상선의 Hürthle씨 세포 종양
- 갑상선암의 외과적 치료
- Beta-4 Integrin Transfection, Cloning and Functional Assay in Squamous Cell Carcinoma
- 갑상선암의 임상적 고찰
- 원발성 이하선 편평상피세포암종
- 경부 낭종의 형태로 발현한 전이암 2례
- 타액선 종양에서 제4형 교원질과 Fibronectin 발현
- 하악골에 발생한 방사선속발 골육종 1례
- 경부 피하조직내에 발생한 기관지성 낭종
- 진행된 상악동암의 병용치료
- 이하선 종양의 임상적 고찰
- 이하선 종양에 관한 임상적 고찰
- 갑상선에 발생한 악성 림프종 1례
- 분화성 갑상선암 환자에서 수술범위의 선택
- 분화성 갑상선암과 공존한 부갑상선 선종
- 이하선에 발생한 소관 선종
- 측두하부와에 발생한 영아섬유종증 1례
참고문헌
관련논문
의약학 > 종양학분야 BEST
- 두피의 포도주색 모반에서 발생한 화농성 육아종: 증례 보고 및 문헌고찰
- 무릎관절의 미만형 색소 융모 결절성 활액막염에서 관절경을 이용한 육안적 활액막 전 절제술 후 방사선치료
- Impact of adaptive radiotherapy on survival in locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy
의약학 > 종양학분야 NEW
- Dosimetric analysis of different whole brain radiotherapy treatment planning methods: three types of 3-dimensional versus hippocampal avoidant
- To irradiate or to wait: practical considerations when planning for stereotactic radiosurgery for kidney tumors using magnetic resonance-guided online adaptive radiotherapy
- Definitive radiotherapy for unresectable extrahepatic cholangiocarcinoma: is it time for an update?
최근 이용한 논문
교보eBook 첫 방문을 환영 합니다!
신규가입 혜택 지급이 완료 되었습니다.
바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!
